Currently, HCC is primarily diagnosed using typical imaging and elevated serum alpha-fetoprotein (AFP) levels, which lack sensitivity and accuracy for HCC screening, with approximately 30% of early-stage patients having normal AFP levels (Galle et al., 2019). Here, AFP is linked to hepatocellular carcinoma.